Exercise training restores aerobic capacity and energy transfer systems in heart failure treated with losartan

Cardiovascular Research

Volumn 76, Issue 1, 2007, Pages 91-99

  Kemi, Ole Johan ^a,b   Høydal, Morten Andre ^a   Haram, Per Magnus ^a,c   Garnier, Anne ^d,e   Fortin, Dominique ^d,e   Ventura Clapier, Renee ^d,e   Ellingsen, Øyvind ^a,f  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d INSERM   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Endurance training; Heart failure; Losartan; Metabolism; Myocardial infarction

Indexed keywords

ADENYLATE KINASE; ANGIOTENSIN; CREATINE; ENZYME; LOSARTAN; OXYGEN;

AEROBIC CAPACITY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY LIGATION; DIASTOLIC BLOOD PRESSURE; ENERGY METABOLISM; ENERGY TRANSFER; ENERGY YIELD; EXERCISE; FEMALE; HEART AFTERLOAD; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE; HEART VENTRICLE PRESSURE; HORMONE INHIBITION; INTERVENTION STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; SYSTOLIC BLOOD PRESSURE;

ADENYLATE KINASE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIOLOGICAL MARKERS; COMBINED MODALITY THERAPY; CREATINE KINASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENERGY TRANSFER; EXERCISE THERAPY; FEMALE; HEART FAILURE; L-LACTATE DEHYDROGENASE; LOSARTAN; MEMBRANE PROTEINS; MODELS, ANIMAL; MYOCARDIUM; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS;

EID: 34548395474     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.06.008     Document Type: Article

References (58)

1. Kavanagh T., Mertens D.J., Hamm L.F., Beyene J., Kennedy J., Corey P., et al. Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation 106 (2002) 666-671
2. Lee I.M., Sesso H.D., Oguma Y., and Paffenbarger Jr. R.S. Relative intensity of physical activity and risk of coronary heart disease. Circulation 107 (2003) 1110-1116
3. Giannuzzi P., Temporelli P.L., Corra U., and Tavazzi L. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial. Circulation 108 (2003) 554-559
4. Wisloff U., Loennechen J.P., Currie S., Smith G.L., and Ellingsen O. Aerobic exercise reduces cardiomyocyte hypertrophy and increases contractility, Ca2+ sensitivity and SERCA-2 in rat after myocardial infarction. Cardiovasc Res 54 (2002) 162-174
5. Zhang L.Q., Zhang X.Q., Musch T.I., Moore R.L., and Cheung J.Y. Sprint training restores normal contractility in postinfarction rat myocytes. J Appl Physiol 89 (2000) 1099-1105
6. Zhang L.Q., Zhang X.Q., Ng Y.C., Rothblum L.I., Musch T.I., Moore R.L., et al. Sprint training normalizes Ca(2+) transients and SR function in postinfarction rat myocytes. J Appl Physiol 89 (2000) 38-46
7. Crozier I., Ikram H., Awan N., Cleland J., Stephen N., Dickstein K., et al. Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group. Circulation 91 (1995) 691-697
8. Gottlieb S.S., Dickstein K., Fleck E., Kostis J., Levine T.B., LeJemtel T., et al. Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation 88 (1993) 1602-1609
9. Pitt B., Poole-Wilson P.A., Segal R., Martinez F.A., Dickstein K., Camm A.J., et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 355 (2000) 1582-1587
10. Pitt B., Segal R., Martinez F.A., Meurers G., Cowley A.J., Thomas I., et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349 (1997) 747-752
11. Daniels M.C., Keller R.S., and de Tombe P.P. Losartan prevents contractile dysfunction in rat myocardium after left ventricular myocardial infarction. Am J Physiol Heart Circ Physiol 281 (2001) H2150-H2158
12. Jain M., Liao R., Ngoy S., Whittaker P., Apstein C.S., and Eberli F.R. Angiotensin II receptor blockade attenuates the deleterious effects of exercise training on post-MI ventricular remodelling in rats. Cardiovasc Res 46 (2000) 66-72
13. Konstam M.A., Patten R.D., Thomas I., Ramahi T., La Bresh K., Goldman S., et al. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy. Am Heart J 139 (2000) 1081-1087
14. Loennechen J.P., Wisloff U., Falck G., and Ellingsen O. Effects of cariporide and losartan on hypertrophy, calcium transients, contractility, and gene expression in congestive heart failure. Circulation 105 (2002) 1380-1386
15. Patten R.D., Aronovitz M.J., Einstein M., Lambert M., Pandian N.G., Mendelsohn M.E., et al. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse. Clin Sci (Lond) 104 (2003) 109-118
16. De Sousa E., Lechene P., Fortin D., N'Guessan B., Belmadani S., Bigard X., et al. Cardiac and skeletal muscle energy metabolism in heart failure: beneficial effects of voluntary activity. Cardiovasc Res 56 (2002) 260-268
17. Ventura-Clapier R., Garnier A., and Veksler V. Energy metabolism in heart failure. J Physiol 555 (2004) 1-13
18. Finck B.N., and Kelly D.P. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116 (2006) 615-622
19. Scarpulla R.C. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 1576 (2002) 1-14
20. Taegtmeyer H. Metabolism-the lost child of cardiology. J Am Coll Cardiol 36 (2000) 1386-1388
21. Taegtmeyer H., Wilson C.R., Razeghi P., and Sharma S. Metabolic energetics and genetics in the heart. Ann N Y Acad Sci 1047 (2005) 208-218
22. De Sousa E., Veksler V., Minajeva A., Kaasik A., Mateo P., Mayoux E., et al. Subcellular creatine kinase alterations. Implications in heart failure. Circ Res 85 (1999) 68-76
23. Dzeja P.P., Pucar D., Redfield M.M., Burnett J.C., and Terzic A. Reduced activity of enzymes coupling ATP-generating with ATP-consuming processes in the failing myocardium. Mol Cell Biochem 201 (1999) 33-40
24. Ingwall J.S., and Weiss R.G. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 95 (2004) 135-145
25. Nascimben L., Ingwall J.S., Pauletto P., Friedrich J., Gwathmey J.K., Saks V., et al. Creatine kinase system in failing and nonfailing human myocardium. Circulation 94 (1996) 1894-1901
26. Spindler M., Engelhardt S., Niebler R., Wagner H., Hein L., Lohse M.J., et al. Alterations in the myocardial creatine kinase system precede the development of contractile dysfunction in beta(1)-adrenergic receptor transgenic mice. J Mol Cell Cardiol 35 (2003) 389-397
27. Ventura-Clapier R., Mettauer B., and Bigard X. Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovasc Res 73 (2007) 10-18
28. Kemi O.J., Arbo I., Hoydal M.A., Loennechen J.P., Wisloff U., Smith G.L., et al. Reduced pH and contractility in failing rat cardiomyocytes. Acta Physiol (Oxf) 188 (2006) 185-193
29. Loennechen J.P., Wisloff U., Falck G., and Ellingsen O. Cardiomyocyte contractility and calcium handling partially recover after early deterioration during post-infarction failure in rat. Acta Physiol Scand 176 (2002) 17-26
30. Litwin S.E., Katz S.E., Morgan J.P., and Douglas P.S. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 89 (1994) 345-354
31. Wisloff U., Helgerud J., Kemi O.J., and Ellingsen O. Intensity-controlled treadmill running in rats: VO(2 max) and cardiac hypertrophy. Am J Physiol Heart Circ Physiol 280 (2001) H1301-H1310
32. Taylor C.R., Maloiy G.M., Weibel E.R., Langman V.A., Kamau J.M., Seeherman H.J., et al. Design of the mammalian respiratory system. III Scaling maximum aerobic capacity to body mass: wild and domestic mammals. Respir Physiol 44 (1981) 25-37
33. Batterham A.M., George K.P., and Mullineaux D.R. Allometric scaling of left ventricular mass by body dimensions in males and females. Med Sci Sports Exerc 29 (1997) 181-186
34. Darveau C.A., Suarez R.K., Andrews R.D., and Hochachka P.W. Allometric cascade as a unifying principle of body mass effects on metabolism. Nature 417 (2002) 166-170
35. Bergmeyer H., and Bernt E. Lactate dehydrogenase. In: Bergmeyer H. (Ed). Methods of Enzymatic Analysis. 2nd edition vol. 2 (1974), Verlag Chemie, New York
36. Srere P. Citrate synthase. In: Colowick S., and Kaplan N. (Eds). Methods in Enzymology. 3rd ed. vol. XIII (1969), Academic Press, London
37. Garnier A., Fortin D., Delomenie C., Momken I., Veksler V., and Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 551 (2003) 491-501
38. Sjaastad I., Sejersted O.M., Ilebekk A., and Bjornerheim R. Echocardiographic criteria for detection of postinfarction congestive heart failure in rats. J Appl Physiol 89 (2000) 1445-1454
39. Adachi H., Koike A., Obayashi T., Umezawa S., Aonuma K., Inada M., et al. Does appropriate endurance exercise training improve cardiac function in patients with prior myocardial infarction?. Eur Heart J 17 (1996) 1511-1521
40. Belardinelli R., Georgiou D., Cianci G., and Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 99 (1999) 1173-1182
41. Wagner P.D. New ideas on limitations to VO2max. Exerc Sport Sci Rev 28 (2000) 10-14
42. Kemi O.J., Haram P.M., Loennechen J.P., Osnes J.B., Skomedal T., Wisloff U., et al. Moderate vs. high exercise intensity: differential effects on aerobic fitness, cardiomyocyte contractility, and endothelial function. Cardiovasc Res 67 (2005) 161-172
43. Kemi O.J., Haram P.M., Wisloff U., and Ellingsen O. Aerobic fitness is associated with cardiomyocyte contractile capacity and endothelial function in exercise training and detraining. Circulation 109 (2004) 2897-2904
44. Moore R.L., Musch T.I., Yelamarty R.V., Scaduto Jr. R.C., Semanchick A.M., Elensky M., et al. Chronic exercise alters contractility and morphology of isolated rat cardiac myocytes. Am J Physiol 264 (1993) C1180-C1189
45. Wisløff U., Loennechen J.P., Falck G., Beisvag V., Currie S., Smith G., et al. Increased contractility and calcium sensitivity in cardiac myocytes isolated from endurance trained rats. Cardiovasc Res 50 (2001) 495-508
46. Azevedo L.F., Brum P.C., Mattos K.C., Junqueira C.M., Rondon M.U., Barretto A.C., et al. Effects of losartan combined with exercise training in spontaneously hypertensive rats. Braz J Med Biol Res 36 (2003) 1595-1603
47. Arany Z., He H., Lin J., Hoyer K., Handschin C., Toka O., et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 1 (2005) 259-271
48. Ventura-Clapier R., Veksler V., and Hoerter J.A. Myofibrillar creatine kinase and cardiac contraction. Mol Cell Biochem 133-134 (1994) 125-144
49. Wallimann T., and Eppenberger H.M. Localization and function of M-line-bound creatine kinase. M-band model and creatine phosphate shuttle. Cell Muscle Motil 6 (1985) 239-285
50. Ventura-Clapier R., Kuznetsov A., Veksler V., Boehm E., and Anflous K. Functional coupling of creatine kinases in muscles: species and tissue specificity. Mol Cell Biochem 184 (1998) 231-247
51. Hugel S., Horn M., de Groot M., Remkes H., Dienesch C., Hu K., et al. Effects of ACE inhibition and beta-receptor blockade on energy metabolism in rats postmyocardial infarction. Am J Physiol 277 (1999) H2167-H2175
52. Nascimben L., Friedrich J., Liao R., Pauletto P., Pessina A.C., and Ingwall J.S. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation 91 (1995) 1824-1833
53. Nahrendorf M., Spindler M., Hu K., Bauer L., Ritter O., Nordbeck P., et al. Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction. Cardiovasc Res 65 (2005) 419-427
54. Kaasik A., Veksler V., Boehm E., Novotova M., Minajeva A., and Ventura-Clapier R. Energetic crosstalk between organelles: architectural integration of energy production and utilization. Circ Res 89 (2001) 153-159
55. Pucar D., Janssen E., Dzeja P.P., Juranic N., Macura S., Wieringa B., et al. Compromised energetics in the adenylate kinase AK1 gene knockout heart under metabolic stress. J Biol Chem 275 (2000) 41424-41429
56. McMullen J.R., Amirahmadi F., Woodcock E.A., Schinke-Braun M., Bouwman R.D., Hewitt K.A., et al. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A 104 (2007) 612-617
57. McMullen J.R., and Jennings G.L. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol 34 (2007) 255-262
58. Rolim N.P.L., Medeiros A., Rosa K.T., Mattos K.C., Irigoyen M.C., Krieger E.M., et al. Exercise Training improves the Net Balance of Cardiac Ca2+ Handling Protein Expression in Heart Failure. Physiol Genomics 29 3 (2007) 246-252 (May 11) [Electronic publication 2007 Jan 23]